share_log

Moderna | 4: Statement of changes in beneficial ownership of securities-Director AFEYAN NOUBAR

SEC announcement ·  Apr 26 19:05
Summary by Moomoo AI
Noubar Afeyan, associated with Moderna, Inc. [MRNA], completed a sale of 15,000 shares of common stock on April 24, 2024. The transactions were executed in the open market with prices ranging from $107.16 to $109.91 per share, resulting in a total market value of $1,624,835.94. Following the sale, Afeyan directly holds 2,041,931 shares. Additionally, indirect holdings through Flagship Ventures Fund IV, L.P., Flagship Ventures Fund IV-Rx, L.P., and Flagship Pioneering, Inc. amount to 9,666,038 shares of Moderna's common stock.
Noubar Afeyan, associated with Moderna, Inc. [MRNA], completed a sale of 15,000 shares of common stock on April 24, 2024. The transactions were executed in the open market with prices ranging from $107.16 to $109.91 per share, resulting in a total market value of $1,624,835.94. Following the sale, Afeyan directly holds 2,041,931 shares. Additionally, indirect holdings through Flagship Ventures Fund IV, L.P., Flagship Ventures Fund IV-Rx, L.P., and Flagship Pioneering, Inc. amount to 9,666,038 shares of Moderna's common stock.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more